FDA Approved: NUPLAZID — Supplemental Application (Acadia Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Acadia's supplemental application for NUPLAZID (pimavanserin tartrate), resulting in an updated labeling for the product. The change relates to Par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease Psychosis

Drugs mentioned

• Nuplazid (Pimavanserin)

Snippet

SUPPL AP for NUPLAZID (PIMAVANSERIN TARTRATE)